Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27,615,000
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
6,178,650
-
Shares change
-
-436,688
-
Total reported value, excl. options
-
$4,511,000
-
Value change
-
-$860,155
-
Number of buys
-
3
-
Number of sells
-
-4
-
Price
-
$0.7302
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q2 2022
13 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q2 2022.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,178,650 shares
of 27,615,000 outstanding shares and own 22.37% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2,813,489 shares), JOHNSON & JOHNSON (2,133,402 shares), MMCAP International Inc. SPC (684,451 shares), ROYCE & ASSOCIATES LP (328,655 shares), MILLENNIUM MANAGEMENT LLC (78,933 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (58,700 shares), RENAISSANCE TECHNOLOGIES LLC (42,200 shares), JANE STREET GROUP, LLC (22,462 shares), UBS Group AG (10,608 shares), and BlackRock Inc. (5,750 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.